[CNBC Television] Squawk Pod: Robert Kraft on the NFL’s $12B Deal & Warren Buffett’s BofA Sale - 08/28/24 | Audio Only
🎯 Загружено автоматически через бота:
🚫 Оригинал видео:
📺 Данное видео принадлежит каналу «CNBC Television» (@CNBCtelevision). Оно представлено в нашем сообществе исключительно в информационных, научных, образовательных или культурных целях. Наше сообщество не утверждает никаких прав на данное видео. Пожалуйста, поддержите автора, посетив его оригинальный канал.
✉️ Если у вас есть претензии к авторским правам на данное видео, пожалуйста, свяжитесь с нами по почте support@, и мы немедленно удалим его.
📃 Оригинальное описание:
NFL owners have voted to allow private equity firms to invest at up to 10% of a team stake. Robert Kraft, owner of the New England Patriots, explains the long-deliberated move for the sport, and what it means for fans and players. Former National Economic Council deputy director Bharat Ramamurti once advised Sen. Elizabeth Warren (D-MA) and now advises the Harris-Walz campaign on economic issues. He discusses VP Harris’ latest “opportunity and accountability” pitch: changes to the tax code. Plus, Warren Buffett is selling more of Berkshire Hathaway’s Bank of America shares, and hotel prices are moving higher and higher.
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
» Subscribe to CNBC TV:
» Subscribe to CNBC:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Instagram:
Follow CNBC News on Facebook:
Follow CNBC on Threads:
Follow CNBC News on X:
#CNBC
#CNBCTV
1 view
0
0
1 week ago 00:03:30 1
[CNBC Television] Two experts discuss what happens to inflation in 2023
1 week ago 00:01:55 1
[CNBC Television] Coronavirus: Here’s an inside look at General Motors’ face mask plant
1 week ago 00:07:10 1
[CNBC Television] GSK CEO: Pfizer venture creates value for both our consumer and pharma businesses